---
layout: post
title: "特一药业2021年度净利同比增189.66% 拟10派6.5元"
date: 2022-03-14 17:22:49 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002728" data-code="002728|0|2" data-code2="002728|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002728&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002728_0" data-code="K 002728|0|2" data-code2="K 002728|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --> <p>特一药业披露年报。公司2021年实现营业收入758,160,497.71元，同比增长19.83%；实现归属于上市公司股东的净利润126,917,422.27元，同比增长189.66%；基本每股收益0.62元/股。公司2021年度利润分配预案为：以权益分派实施时股权登记日的总股本为基数，向全体股东每10股派发现金红利6.50元(含税)。</p><p class="em_media">（文章来源：上海证券报·中国证券网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203142308308189>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)